Skip to content

NaRCAD2026 Day 1 Evaluation

1.MAIN SESSION: Day 1 Kick-Off & Opening Remarks (Mike Fischer & Anna Morgan-Barsamian, 9:00 a.m. - 9:30 a.m.)(Required.)
Strongly Disagree
Somewhat Disagree
Neither Agree nor Disagree
Somewhat Agree
Strongly Agree
I did not attend this session
The presentation was relevant to my work.
The session offered sufficient opportunities for interactivity and audience engagement.
The content was of high quality.
The presenter(s) was/were highly knowledgeable on this topic.
2.MAIN SESSION: Keynote: Annual AD Talk with Jerry Avorn, MD (9:30 a.m.-10:30 a.m.)(Required.)
Strongly Disagree
Somewhat Disagree
Neither Agree nor Disagree
Somewhat Agree
Strongly Agree
I did not attend this session
The presentation was relevant to my work.
The session offered sufficient opportunities for interactivity and audience engagement.
The content was of high quality.
The presenter(s) was/were highly knowledgeable on this topic.
3.MAIN SESSION: Field Presentations: “Expansive Applications: Exploring Advancements in AD” (Pres. 1: Dima Cheetany & Chirag Rathod: "ADVANCEing the Human Touch With AI” | Pres. 2: Megan Pruitt: "A Decade of S.O.S. for Safer Opioid Prescribing” | Pres. 3: Kurt Begaye: "Detailing in Native Communities”, 10:45 a.m. - 12:15 p.m.)(Required.)
Strongly Disagree
Somewhat Disagree
Neither Agree nor Disagree
Somewhat Agree
Strongly Agree
I did not attend this session
The presentation was relevant to my work.
The session offered sufficient opportunities for interactivity and audience engagement.
The content was of high quality.
The presenter(s) was/were highly knowledgeable on this topic.